Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Centessa Pharmaceuticals (CNTA) Shares Outstanding (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Shares Outstanding for 4 consecutive years, with $149.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 12.51% to $149.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $149.2 million through Dec 2025, up 12.51% year-over-year, with the annual reading at $149.2 million for FY2025, 12.51% up from the prior year.
  • Shares Outstanding for Q4 2025 was $149.2 million at Centessa Pharmaceuticals, up from $134.4 million in the prior quarter.
  • The five-year high for Shares Outstanding was $149.2 million in Q4 2025, with the low at $94.0 million in Q1 2022.
  • Average Shares Outstanding over 4 years is $112.1 million, with a median of $99.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding rose 1.09% in 2023, then surged 34.94% in 2024.
  • Over 4 years, Shares Outstanding stood at $94.8 million in 2022, then increased by 4.15% to $98.8 million in 2023, then skyrocketed by 34.28% to $132.6 million in 2024, then increased by 12.51% to $149.2 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $149.2 million, $134.4 million, and $133.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.